Reaching 100 sounds like a miracle, yet ultimately, biology still negotiates the deal. One new study asked whether meat ...

Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...

This afternoon, we released financial results for the quarter and full year ended December 31, 2025, and recent corporate updates. The press release is available on the Investors section of our ...

Explore the systemic hurdles of India's district judiciary, from arbitrary judge dismissals to data gaps, as highlighted in the book Tareekh Pe Justice.

Every day, millions of people input prompts (whether questions or instructions) into AI tools such as ChatGPT, Perplexity, Claude, DALL-E, or Meta AI. Recently, media coverage highlighted what seemed ...

CEO Mark Goldsmith outlined the company’s late-stage plans for its RAS(ON) inhibitor daraxonrasib, discussed expansion into ...

Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and ...

This study proposes a cross-species transcriptomic framework to predict vaccine reactogenicity, with implications for preclinical vaccine safety assessment. The findings show that mouse muscle ...

Inflammatory bowel disease (IBD) is typically diagnosed after the onset of symptoms in the context of established, characteristic patterns of intestinal inflammation. However, there is now substantial ...

Head zepbound beats novo in a phase 3 trial showing greater weight loss among adults with obesity and comorbidities.

Much uncertainty remains in the evidence base for child and adolescent health. Not only is the quality of clinical trials involving neonates, children, and adolescents inconsistent; in numbers, they ...

A federal FOIA lawsuit, with a decision dated September 24, 2025, is forcing the release of internal CDC emails and spreadsheets that reveal how a disputed thimerosal study moved through agency review ...